BioSpace News Archive

Press Releases

Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)

June 23, 2026
·
14 min read
Press Releases

Osanni Bio Closes $190 Million Series B Financing Led by Patient Square Capital

June 23, 2026
·
2 min read
Press Releases

BioMendics Receives FDA Fast Track Designation for BM-3103 (TolaSure® Gel™) for Epidermolysis Bullosa Simplex

June 23, 2026
·
4 min read
Press Releases

Hope Biosciences Reports Positive Published Clinical Data Following Stem Cell Therapy in Chronic Traumatic Brain Injury

June 23, 2026
·
2 min read
Press Releases

Silexion Therapeutics Receives Approval from Germany’s BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

June 23, 2026
·
7 min read
Press Releases

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome

June 23, 2026
·
6 min read
Press Releases

Takeda’s Zasocitinib Achieved Significantly Greater Complete Skin Clearance Than Deucravacitinib in Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

June 23, 2026
·
14 min read
Press Releases

Rapalogix Health Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin Health

June 23, 2026
·
5 min read
Press Releases

Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients

June 23, 2026
·
15 min read
Press Releases

Calico Life Sciences Announces Fosigotifator Granted Breakthrough Therapy Designation by the U.S. FDA for the Treatment of Vanishing White Matter Disease

June 23, 2026
·
5 min read